Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: The Effect of Pretreatment With Roc on Succinylcholine Myalgias [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether pretreatment with rocuronium reduces succinylcholine-induced myalgias; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rocuronium (rocuronium bromide)
  • Succinylcholine (succinylcholine chloride)

Snippet

Sponsor: Indiana University | Conditions: Myalgia | Phase 3 | Status: COMPLETED | Results posted: 2024-05-16